Proopiomelanocortin deficiency diagnosed in infancy in two boys and a review of the known cases
- PMID: 33666293
- DOI: 10.1111/jpc.15407
Proopiomelanocortin deficiency diagnosed in infancy in two boys and a review of the known cases
Abstract
Proopiomelanocortin (POMC) deficiency is a rare monogenic disorder characterised by adrenocorticotropic hormone (ACTH) deficiency, red hair and hyperphagic obesity. Two unrelated cases presented with hypoglycaemia due to isolated ACTH deficiency in the neonatal period. POMC deficiency was suspected at age 2 years (c.133-2A>C) and at age 9 months (c.64del) due to infantile hyperphagic obesity. Neither patient had a convincing red hair phenotype at the time of diagnostic suspicion, illustrating the importance of suspecting POMC deficiency in isolated ACTH deficiency. Both patients have normal psychomotor development, whereas the only other reported case of c.64del had significant delay. This suggests, if ACTH deficiency is treated early in the neonatal period, that psychomotor retardation is not a part of the phenotype. We review 24 reported cases of POMC deficiency published to date. Although there is no current specific treatment for obesity in POMC deficiency, we anticipate that setmelanotide may be a useful future treatment option.
Keywords: adrenal insufficiency; infantile obesity; monogenic obesity; proopiomelanocortin.
© 2021 Paediatrics and Child Health Division (The Royal Australasian College of Physicians).
Similar articles
-
Two Cases With an Early Presented Proopiomelanocortin Deficiency-A Long-Term Follow-Up and Systematic Literature Review.Front Endocrinol (Lausanne). 2021 Jun 9;12:689387. doi: 10.3389/fendo.2021.689387. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34177811 Free PMC article.
-
Delayed diagnosis of proopiomelanocortin (POMC) deficiency with type 1 diabetes in a 9-year-old girl and her infant sibling.J Pediatr Endocrinol Metab. 2017 Oct 26;30(10):1137-1140. doi: 10.1515/jpem-2017-0064. J Pediatr Endocrinol Metab. 2017. PMID: 28915118
-
A novel mutation in the proopiomelanocortin (POMC) gene of a Hispanic child: metformin treatment shows a beneficial impact on the body mass index.J Pediatr Endocrinol Metab. 2018 Jul 26;31(7):815-819. doi: 10.1515/jpem-2017-0467. J Pediatr Endocrinol Metab. 2018. PMID: 29858905
-
A Patient with Proopiomelanocortin Deficiency: An Increasingly Important Diagnosis to Make.J Clin Res Pediatr Endocrinol. 2018 Mar 1;10(1):68-73. doi: 10.4274/jcrpe.4638. Epub 2017 Jul 24. J Clin Res Pediatr Endocrinol. 2018. PMID: 28739551 Free PMC article.
-
Implications of proopiomelanocortin (POMC) mutations in humans: the POMC deficiency syndrome.Trends Endocrinol Metab. 2000 Jan-Feb;11(1):15-22. doi: 10.1016/s1043-2760(99)00213-1. Trends Endocrinol Metab. 2000. PMID: 10652501 Review.
Cited by
-
Neuroendocrine Effects on the Risk of Metabolic Syndrome in Children.Metabolites. 2023 Jun 29;13(7):810. doi: 10.3390/metabo13070810. Metabolites. 2023. PMID: 37512517 Free PMC article. Review.
-
Rare genetic forms of obesity in childhood and adolescence, a comprehensive review of their molecular mechanisms and diagnostic approach.Eur J Pediatr. 2023 Nov;182(11):4781-4793. doi: 10.1007/s00431-023-05159-x. Epub 2023 Aug 23. Eur J Pediatr. 2023. PMID: 37607976 Review.
-
Step-by-Step Double-Trouble OBAIRH and DMD Diagnosis in a One-Year-Old Boy.Int J Mol Sci. 2023 Aug 2;24(15):12357. doi: 10.3390/ijms241512357. Int J Mol Sci. 2023. PMID: 37569734 Free PMC article.
-
The promise of new anti-obesity therapies arising from knowledge of genetic obesity traits.Nat Rev Endocrinol. 2022 Oct;18(10):623-637. doi: 10.1038/s41574-022-00716-0. Epub 2022 Jul 28. Nat Rev Endocrinol. 2022. PMID: 35902734 Free PMC article. Review.
References
-
- Krude H, Biebermann H, Luck W, Horn R, Brabant G, Gruters A. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat. Genet. 1998; 19: 155-7.
-
- Challis BG, Millington GWM. Adam MP, Ardinger HH, Pagon RA et al., eds. Proopiomelanocortin Deficiency. Seattle, WA: GeneReviews®; 1993.
-
- Aslan IR, Ranadive SA, Valle I, Kollipara S, Noble JA, Vaisse C. The melanocortin system and insulin resistance in humans: Insights from a patient with complete POMC deficiency and type 1 diabetes mellitus. Int. J. Obes. (Lond) 2014; 38: 148-51.
-
- Anisimova AS, Rubtsov PM, Akulich KA, Dmitriev SE, Frolova E, Tiulpakov A. Late diagnosis of POMC deficiency and in vitro evidence of residual translation from allele with c.-11C>A mutation. J. Clin. Endocrinol. Metab. 2017; 102: 359-62.
-
- Ozen S, Ozcan N, Ucar SK, Goksen D, Darcan S. Unexpected clinical features in a female patient with proopiomelanocortin (POMC) deficiency. J. Pediatr. Endocrinol. Metab. 2015; 28: 691-4.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous